share_log

东方证券承销保荐有限公司关于浙江华康药业股份有限公司2023年度日常关联交易及2024年度预计日常关联交易的核查意见

Orient Securities Underwriting and Sponsorship Co., Ltd.'s inspection opinions on Zhejiang Huakang Pharmaceutical Co., Ltd.'s daily related transactions in 2023 and expected daily related transactions in 2024

Sensex a share ·  Apr 18
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more